Volume 22, Issue 4
Feature

Rethinking agency and medical adherence technology: applying Actor Network Theory to the case study of Digital Pills

Alejandra Hurtado‐de‐Mendoza

Corresponding Author

Georgetown University Medical Center, Washington, DC, USA

Co‐First Authors.

Correspondence: Alejandra Hurtado‐de‐Mendoza, Georgetown University Medical Center, 3300 Whitehaven St. NW, Suite 4100, Washington, DC 20007, USA.

E‐mail: <ahd28@georgetown.edu>

Search for more papers by this author
Mark L Cabling

Georgetown University Medical Center, Washington, DC, USA

Co‐First Authors.Search for more papers by this author
Vanessa B Sheppard

Georgetown University Medical Center, Washington, DC, USA

Search for more papers by this author
First published: 30 April 2015
Citations: 3

Abstract

Much literature surrounding medical technology and adherence posits that technology is a mechanism for social control. This assumes that the medical establishment can take away patients' agency. Although power relationships and social control can play a key role, medical technology can also serve as an agentive tool to be utilized. We (1) offer the alternative framework of Actor Network Theory to view medical technology, (2) discuss the literature on medication adherence and technology, (3) delve into the ramifications of looking at adherence as a network and (4) use Digital Pills as a case study of dispersed agency.

Number of times cited according to CrossRef: 3

  • Ingestible Sensors and Medication Adherence: Focus on Use in Serious Mental Illness, Pharmacy, 10.3390/pharmacy8020103, 8, 2, (103), (2020).
  • Providers’ perspectives on adherence to hormonal therapy in breast cancer survivors. Is there a role for the digital health feedback system?, Health and Technology, 10.1007/s12553-018-0267-x, (2018).
  • How to Screen for Non-Adherence to Antihypertensive Therapy, Current Hypertension Reports, 10.1007/s11906-016-0697-7, 18, 12, (2016).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.